Perioperative chemotherapy

DRUG5 trials

Sponsors

Department of Surgical Oncology, Kanazawa Medical University, Alberta Health services, European Institute of Oncology, NSABP Foundation Inc, Richard van Hillegersberg

Conditions

Breast NeoplasmsCarcinomaColorectal AdenocarcinomaColorectal CancerGastric CancerHIPECLiver MetastasesMetastatic Cancer

Phase 2

Study of 5-FU + Leucovorin + CPT-11 in Patients With Resectable Liver Metastases From Colorectal Adenocarcinoma

CompletedNCT00168155

Alberta Health servicesColorectal Adenocarcinoma, Liver Metastases

Start: 2002-01-31End: 2009-05-31Target: 70Updated: 2012-01-19

Perioperative Chemotherapy After Primary Chemotherapy for Locally Advanced Breast Cancer

CompletedNCT00301548

European Institute of OncologyBreast Neoplasms, Carcinoma

Start: 2000-02-29End: 2005-06-30Target: 172Updated: 2006-03-13

Prospective Cohort Study Evaluating the Prognosis of Patients with Resectable Large 3 and 4 Type Gastric Cancer and Clinical Phase II trial Evaluating the Safety and Benefit of Perioperative Chemotherapy for Resectable Large 3 and 4 Type Gastric Cancer

RecruitingJPRN-UMIN000013491

Department of Surgical Oncology, Kanazawa Medical Universitygastric cancer

Start: 2014-01-01Target: 40Updated: 2025-07-18

Cytoreductive Surgery and Intraperitoneal Chemotherapy for Stomach CAncer: a Feasibility Study

TerminatedNCT03150628

Richard van HillegersbergGastric Cancer, HIPEC, Peritoneal Carcinomatosis

Start: 2017-08-01End: 2018-04-23Updated: 2019-04-17

Phase 3

Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery

TerminatedNCT01189227

NSABP Foundation IncColorectal Cancer, Metastatic Cancer

Start: 2010-08-31End: 2011-12-31Updated: 2013-05-10

Related Papers

A phase II experience with neoadjuvant irinotecan (CPT-11), 5-fluorouracil (5-FU) and leucovorin (LV) for colorectal liver metastases.

2009-05-2022 citations